α-parvin Activators are a group of chemical compounds that can logically enhance the functional activity of α-parvin, a key component of focal adhesion complexes. The primary mechanism of action of these activators is through the manipulation of intracellular signaling pathways that lead to the activation of binding partners of α-parvin or modulate the stability of the focal adhesion complex where α-parvin operates. For instance, Phorbol 12-myristate 13-acetate (PMA) and Forskolin promote the activation of protein kinase C (PKC) and protein kinase A (PKA), respectively. Both PKC and PKA can phosphorylate and activate integrin-linked kinase (ILK), a known binding partner of α-parvin. The activation of ILK can enhance the function of α-parvin within focal adhesion complexes. Furthermore, Blebbistatin and Y-27632 inhibit non-muscle myosin II and ROCK, respectively. These inhibitions reduce stress fiber formation, fostering a more stable environment for α-parvin to function within focal adhesions.
Compounds like Jasplakinolide, Nocodazole, Paclitaxel, Colchicine, Cytochalasin D, andLatrunculin A exert their influence by modulating the cytoskeletal dynamics, which are integral to the stability of focal adhesions. Jasplakinolide stabilizes F-actin, a crucial component of focal adhesions, thereby indirectly enhancing the functional environment of α-parvin. Nocodazole and Colchicine destabilize and bind to tubulin, respectively, altering microtubule dynamics to favor increased stability of focal adhesions, indirectly enhancing α-parvin's function. Paclitaxel, on the other hand, stabilizes microtubules, leading to a similar effect. Cytochalasin D and Latrunculin A stop actin polymerization and depolymerization, creating a more stable environment for focal adhesions, indirectly improving the functioning of α-parvin. Lastly, Calyculin A and Okadaic Acid inhibit protein phosphatases 1 and 2A, leading to increased phosphorylation of proteins. This can potentially boost the phosphorylation and activation of ILK, a key binding partner of α-parvin, thereby enhancing α-parvin function. Through these varied but interconnected mechanisms, α-parvin activators can enhance the functional activity of α-parvin, contributing to the stability and function of focal adhesion complexes.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which phosphorylates and activates integrin-linked kinase (ILK). ILK is a known binding partner of α-parvin, and its activation can enhance the function of α-parvin within focal adhesion complexes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin increases cAMP levels, leading to the activation of PKA. PKA can phosphorylate and activate ILK, which is a direct binding partner of α-parvin. Activated ILK can enhance the function of α-parvin at focal adhesions. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Jasplakinolide stabilizes F-actin, an important component in focal adhesions. By stabilizing F-actin, Jasplakinolide indirectly enhances the functional environment of α-parvin. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Nocodazole destabilizes microtubules, which can increase the stability of focal adhesions. With enhanced stability of focal adhesions, α-parvin's activity can be indirectly enhanced. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation of proteins. This can potentially increase the phosphorylation and activation of ILK, a key binding partner of α-parvin, thereby enhancing α-parvin function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A. Similar to Calyculin A, it can potentially increase the phosphorylation and activation of ILK, thereby enhancing α-parvin function. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Taxol stabilizes microtubules, which can lead to increased stability of focal adhesions. Enhanced stability of focal adhesions can indirectly enhance α-parvin's function. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $98.00 $315.00 $2244.00 $4396.00 $17850.00 $34068.00 | 3 | |
Colchicine binds to tubulin, disrupting microtubule dynamics. This perturbation can lead to an increased stability of focal adhesions, indirectly enhancing α-parvin's function. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Cytochalasin D caps the plus ends of actin filaments, preventing polymerization and depolymerization. This creates a more stable environment for focal adhesions, indirectly improving the functioning of α-parvin. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
Latrunculin A binds to actin monomers, preventing their polymerization. This can lead to increased stability of focal adhesions, indirectly enhancing α-parvin's function. |